Direkt zum Inhalt
Merck
  • Hypothyroidism-related onycholysis with Aureobasidium pullulans colonization successfully treated with antifungal therapy.

Hypothyroidism-related onycholysis with Aureobasidium pullulans colonization successfully treated with antifungal therapy.

Clinical and experimental dermatology (2012-03-24)
M Arabatzis
ZUSAMMENFASSUNG

This is a report, the first to my knowledge, of secondary nail-apparatus involvement by Aureobasidium pullulans in a patient with onycholysis related to hypothyroidism. Complete cure of the lesions was seen after 2 weeks of itraconazole and 2 months of local bifonazole therapy. This case raises concern about the extent of involvement of this yeast in onycholysis of diverse clinical aetiologies.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Bifonazol, ≥98% (HPLC)
Supelco
Bifonazol, Pharmaceutical Secondary Standard; Certified Reference Material
Bifonazol, European Pharmacopoeia (EP) Reference Standard